[Form 4] BioSig Technologies, Inc. Insider Trading Activity
Streamex Corp. (STEX) director Morgan Lekstrom reported an indirect open-market purchase of the company’s common stock. On 11/21/2025, a total of 7,000 shares of common stock were acquired at a price of $3.58 per share, coded as a purchase transaction. After this trade, the reporting person is shown as beneficially owning 7,000 shares.
The filing states that these shares are held indirectly through All Mine Consulting Ltd., an entity over which the reporting person has voting and dispositive control. The Form 4 is filed as a single-reporting-person filing and reflects only non-derivative equity securities, with no derivative positions reported in Table II.
- None.
- None.
FAQ
What insider transaction was reported for Streamex Corp. (STEX)?
The filing reports that director Morgan Lekstrom acquired 7,000 shares of Streamex Corp. common stock in an open-market purchase on 11/21/2025 at $3.58 per share.
Is the Streamex Corp. insider ownership direct or indirect in this Form 4?
The reported 7,000 shares are held indirectly through All Mine Consulting Ltd., which the reporting person controls for voting and dispositive decisions.
What is the reporting person’s relationship to Streamex Corp. (STEX)?
The reporting person, Morgan Lekstrom, is identified as a director of Streamex Corp., as indicated in the relationship section of the filing.
Were any derivative securities reported in this Streamex Corp. Form 4?
No derivative securities are reported. Table II for derivative securities is present but contains no listed derivative transactions or holdings.
How many Streamex Corp. shares does the insider beneficially own after the transaction?
Following the reported transaction, the filing shows the reporting person as beneficially owning 7,000 shares of Streamex Corp. common stock, held indirectly through All Mine Consulting Ltd.
What transaction code was used in the Streamex Corp. Form 4 filing?
The transaction is identified with code P in Table I, indicating an open-market or private purchase of non-derivative common stock.